Clinical and Histopathological Characteristics of HER2 Low-Expressing Breast Cancer

被引：0
|
作者：
Lee, Soo Hyun [1 ]
Young, Kristen [2 ]
Sofoluwe, Adeyemi [2 ]
Jacoba, Isa [1 ]
Narasimhan, Ramya [2 ]
Zhao, Qing [1 ]
Zuo, Tao [3 ]
机构：
[1] Boston Univ, Sch Med, Boston Med Ctr, Boston, MA 02118 USA
[2] Boston Med Ctr, Boston, MA USA
[3] Boston Univ, Mallory Pathol Associates, Boston, MA 02215 USA
来源：
LABORATORY INVESTIGATION | 2023年 / 103卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
174
引用
收藏
页码：S162 / S163
页数：2
相关论文
共 50 条
  • [1] The characteristics of HER2 low-expressing breast cancer: a China single-center real-world data analysis
    Chen, Caiping
    Li, Wang
    Wu, Wanxin
    Lu, Xiang
    BREAST CANCER MANAGEMENT, 2023, 12 (04)
  • [2] Prognostic Value and Molecular Landscape of HER2 Low-Expressing Metastatic Colorectal Cancer
    Yagisawa, Masataka
    Sawada, Kentaro
    Nakamura, Yoshiaki
    Fujii, Satoshi
    Yuki, Satoshi
    Komatsu, Yoshito
    Yoshino, Takayuki
    Sakamoto, Naoya
    Taniguchi, Hiroya
    CLINICAL COLORECTAL CANCER, 2021, 20 (02) : 113 - +
  • [3] Efficacy and prognosis of neoadjuvant chemotherapy in HER2 low-expressing breast cancer: a retrospective single-center study
    Yao, Yarong
    Zhen, Huifen
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [4] XMT-1522 induces tumor regressions in pre-clinical models representing HER2-positive and HER2 low-expressing breast cancer
    Bergstrom, D. A.
    Bodyak, N.
    Park, P. U.
    Yurkovetskiy, A.
    DeVit, M.
    Yin, M.
    Poling, L.
    Thomas, J. D.
    Gumerov, D.
    Xiao, D.
    Ter-Ovanesyan, E.
    Qin, L.
    Uttard, A.
    Johnson, A.
    Lowinger, T. B.
    CANCER RESEARCH, 2016, 76
  • [5] COMBINATION OF HER2 ADC AND LEMZOPARLIMAB ELICITS ENHANCED EFFICACY IN BOTH HER2 HIGH-AND LOW-EXPRESSING BREAST AND GASTRIC CANCERS
    Zhang, Yanni
    Pang, Yu
    Li, Ao
    Xu, Ke
    Yang, Ming
    Wang, Zhengyi
    Zhu, Andrew
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A898 - A898
  • [6] Early efficacy analysis of the AE37 vaccine in patients with HER2 low-expressing and triple-negative breast cancer
    Mittendorf, Elizabeth Ann
    Perez, Sonia A.
    Hale, Diane F.
    Vreeland, Timothy J.
    Sears, Alan K.
    Clifton, Guy T.
    Ardavanis, Alexandros
    Shumway, Nathan M.
    Murray, James L.
    Ponniah, Sathibalan
    Papamichail, Michael
    Peoples, George Earl
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [7] Characteristics and clinical differences of breast cancer patients with negative or low HER2 expression
    Voutsadakis, Ioannis
    Rosso, Christopher
    CANCER RESEARCH, 2022, 82 (04)
  • [8] Clinical characteristics and therapeutic direction of HER2 low-expression breast cancer
    Zhou, Linlin
    Zhang, Yinghui
    Zhang, Jiayu
    Wang, Hongyu
    Zhao, Bozhi
    Cai, Yixin
    Qu, Yuansong
    Li, Xinxin
    Zhang, Dongwei
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [9] Characteristics, Clinical Differences and Outcomes of Breast Cancer Patients with Negative or Low HER2 Expression
    Rosso, Christopher
    Voutsadakis, Ioannis A.
    CLINICAL BREAST CANCER, 2022, 22 (04) : 391 - 397
  • [10] HER2 low and ER low breast cancer
    Schnitt, Stuart
    JOURNAL OF PATHOLOGY, 2023, 261 (SUPPL1): : S7 - S7
12345